Optech Ventures, LLC
USPTO PatentsView assignee record - 8 granted patents across 11 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Optech ranks #32,753 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 11 technology areas.
- #32,753
- of 49,997 US assignees by volume
- 42nd percentile
- by Innovation Score (32.8/100)
- 22.5
- avg claims per patent
- -67%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R32753 · US Corporation #32,753 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 8 grants
- MID-PACK #32,753/49,997
- PHOTO-FINISH Opal Labs
- CPC-FOCUS A61B · 11 areas
- INNOV-THIN 32.8/100
- CLAIMS-DENSE 22.5 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -67% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Opal Labs Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Optech’s 32.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Optech
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Optech Ventures · this assignee 33
Optech Ventures · this assignee
33 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Optech's Innovation Score is 32.8/100 (42nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Optech?
Each dot is one of Optech’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Optech’s own 22.5 claims/patent is ABOVE the 18.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Optech's grants concentrate
Optech Ventures, LLC is a focused PatentsView assignee: 11 CPC subclasses with 37.5% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2019 (3 grants) versus a trough of 1 in 2018. By volume, Optech sits between Opal Labs Inc. and Optivolt Labs, Inc..
Who files at Optech's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Opal Labs
Opal Labs Inc.
8 patents
- Opera Software Ir…
Opera Software Ireland Limited
8 patents
- Opsera
Opsera Inc.
8 patents
- Optmed
OptMed, Inc.
8 patents
- Opteon
Opteon Corporation
8 patents
- Optimal Ventures
Optimal Ventures, LLC
8 patents
- Optimus Drugs Pri…
Optimus Drugs Private Limited
8 patents
- Optivolt Labs
Optivolt Labs, Inc.
8 patents
- Optech Ventures ◀
Optech Ventures, LLC
8 patents
What this shows Optech holds 8 patents at rank #32,752, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Optech
By rank, the assignees closest to #32,752 in granted patent volume.
- Opal Labs Inc. #32,748 · 8 patents
- Opera Software Ireland Limited #32,749 · 8 patents
- Opsera Inc. #32,750 · 8 patents
- OptMed, Inc. #32,751 · 8 patents
- Opteon Corporation #32,753 · 8 patents
- Optimal Ventures, LLC #32,754 · 8 patents
- Optimus Drugs Private Limited #32,755 · 8 patents
- Optivolt Labs, Inc. #32,756 · 8 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Optech's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Optech's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
33 42nd percentile higher than 42% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 25.0% |
| 2018 | 1 | 12.5% |
| 2019 | 3 | 37.5% |
| 2020 | 1 | 12.5% |
| 2021 | 1 | 12.5% |
Which technologies does Optech Ventures, LLC patent most?
Top 11 of 11 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Optech Ventures, LLC's patent record in context - here's where to go next.
- Optech Ventures, LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 37.5% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #32,753 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Optech Ventures, LLC against Opal Labs Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 32.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.